Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 23,834 | 20,140 | 18,245 | 17,610 | 18,697 |
| Operating Income | -23,834 | -20,140 | -18,245 | -17,610 | -18,697 |
| Other Income | 884 | 848 | 818 | 682 | 1,208 |
| Pre-tax Income | -22,950 | -19,292 | -17,427 | -16,928 | -17,489 |
| Net Income Continuous | -22,950 | -19,292 | -17,427 | -16,928 | -17,489 |
| Net Income | $-22,950 | $-19,292 | $-17,427 | $-16,928 | $-17,489 |
| EPS Basic Total Ops | -6.24 | -4.96 | -4.80 | -5.12 | -5.76 |
| EPS Basic Continuous Ops | -6.25 | -5.15 | -4.76 | -5.04 | -5.76 |
| EPS Diluted Total Ops | -6.24 | -4.96 | -4.80 | -5.12 | -5.76 |
| EPS Diluted Continuous Ops | -6.25 | -5.15 | -4.76 | -5.04 | -5.76 |
| EBITDA(a) | $-23,323 | $-19,605 | $-17,713 | $-17,131 | $-18,223 |